Nature, Published online: 18 November 2026; doi:10.1038/s41586-026-11333-6
Ferroptotic cancer cells activate a molecular program that causes increased levels of PGE2, which in turn impairs type 1 conventional dendritic cell function, compromising antitumour CD8+ T cell immunity.Ferroptosis in cancer cells triggers PGE<sub>2</sub> production for tumour immune escape
Nature, Published online: 18 November 2026; doi:10.1038/s41586-026-11333-6Ferroptotic cancer cells activate a molecular program that causes increased levels of PGE2, which in turn impairs type 1 conventional dendritic cell function, co…